$AUPH

$17.25 +$0.21 (1.23%) Close

$AUPH Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 133.1M shares outstanding

Who owns AUPH?

By type of holder

Institutions 59.2% Insiders 22.2% Everyone else 18.6%

Concentration Top 10 holders own 49.1%

Tang Capital Management LLC 9.8% · Kevin Tang 9.8%

Institutional ownership

59.2%

+3.6 pts vs last qtr

Institutional holders

281

+21 vs last qtr

Net shares bought

+4.8M

by institutions in Q2 2026

New / sold out

49 / 28

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Goldman Sachs Group Inc +4.2M
Allianz Asset Management GmbH NEW +841.7K

Biggest sellers in Q2 2026

Man Group plc −867.5K
Janus Henderson Group PLC SOLD OUT −757.4K

Who is planning to sell?

Notices of proposed sale, last 12 months

$124M

6 notices from 4 people

Shares covered

4.4M

3.32% of the company

Arranged in advance

of the value is under a 10b5-1 plan

Under a 10b5-1 plan No plan

Largest proposed sellers

Gregory Keenan Former affiliate $54.7M
Peter Greenleaf Former affiliate $49.7M

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2020–FY2025

+17.1%

+3.20% a year

Each share's claim on the business

−14.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

$138M vs $173M

over 6 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years36% 3–5 years28% 1–3 years26% Under 1 year9%

Quarterly turnover

12.3%

of institutional shares changed hands

Top 10 managers, median time held

5 years

Super Investors

Investment managers reporting AUPH on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
TC Tang Capital Management LLC 13D · 10.0%	13.0M	9.80%	+814.6K (+6.7%)	2023	10.1%
Shares held by quarter Peak holding13.0M (Q2'26) Change over 8 quarters+5.8M Share of the company9.800% Disclosed stake13D · 10.0% Tang Capital Management LLC's full portfolio →
B BlackRock, Inc.	8.2M	6.16%	+347.6K (+4.4%)	≤2021	0.0%
Shares held by quarter Peak holding9.1M (Q3'24) Change over 8 quarters−872.8K Share of the company6.160% BlackRock, Inc.'s full portfolio →

Tang Capital Management LLC

13D · 10.0%

13.0M

% of company

9.80%

Change vs last qtr

+814.6K (+6.7%)

Held since

2023

BlackRock, Inc.

8.2M

% of company

6.16%

Change vs last qtr

+347.6K (+4.4%)

Held since

≤2021

28 more super investors behind a free account

See every manager holding Aurinia Pharmaceuticals Inc., how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting AUPH on Form N-PORT; together they hold 11.8% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
IR iShares Russell 2000 ETF iShares Trust	$52M	3.1M	2.30%	0.06%	June 30, 2026
FS Fidelity Small Cap Index Fund Fidelity Salem Street Trust	$19.4M	1.3M	0.98%	0.06%	July 31, 2026

iShares Russell 2000 ETF

iShares Trust

Position value

$52M

% of company

2.30%

% of the fund

0.06%

As of

June 30, 2026

Fidelity Small Cap Index Fund

Fidelity Salem Street Trust

Position value

$19.4M

% of company

0.98%

% of the fund

0.06%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding Aurinia Pharmaceuticals Inc. and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
KT Kevin Tang 5%+ holder 13D · 10.0%	13.0M	9.80%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company9.800% Disclosed stake13D · 10.0% View the 13D/G filing →
TC Tang Capital Partners, LP 5%+ holder 13D · 5.6%	7.2M	5.42%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company5.420% Disclosed stake13D · 5.6% View the 13D/G filing →

Kevin Tang

5%+ holder13D · 10.0%

13.0M

% of company

9.80%

Change vs last qtr

—

Held since

—

Tang Capital Partners, LP

5%+ holder13D · 5.6%

7.2M

% of company

5.42%

Change vs last qtr

—

Held since

—

15 more holders behind a free account

See every insider and 5%+ holder of Aurinia Pharmaceuticals Inc..

Comments